Table 3 Financial challenges by participants sociodemographic and clinical characteristics
From: Perception of Cervical Cancer Patients on their Financial Challenges in Western Kenya
| Characteristics | Cost of treatment (%) | Cost of Medication (%) | Cost of home and childcare (%) | Cost of clothes and wigs (%) | Cost of diagnosis (%) | Cost of travel (%) | Cost of Nutritional supplements (%) | N (%) |
|---|---|---|---|---|---|---|---|---|
| Cancer stage | ||||||||
| I | 0 | 41 (14) | 0 | 0 | 10 (4) | 42 (15) | 30 (14) | 52 (16) |
| II | 30 (13) | 30 (10) | 30 (38) | 30 (33) | 30 (12) | 30 (11) | 20 (9) | 40 (12) |
| III | 52 (23) | 52 (18) | 10 (12) | 10 (11) | 52 (21) | 52 (18) | 42 (19) | 63 (19) |
| IV | 146 (64) | 168 (58) | 40 (50) | 51 (56) | 158 (63) | 157 (56) | 125 (58) | 179 (54) |
| Marital status | ||||||||
| Married | 73 (32) | 94 (32) | 20 (5) | 31 (34) | 84 (34) | 83 (30) | 73 (34) | 104 (31) |
| Divorced | 10 (4) | 20 (7) | 10 (12) | 10 (11) | 10 (4) | 20 (7) | 20 (9) | 31 (9) |
| Widowed | 134 (59) | 156 (54) | 50 (63) | 50 (55) | 135 (54) | 167 (59) | 114 (52) | 178 (53) |
| Single | 11 (5) | 21 (7) | 0 | 0 | 21 (8) | 11 (4) | 10 (5) | 21 (7) |
| HIV Status | ||||||||
| Positive | 135 (59) | 177 (61) | 50 (63) | 50 (55) | 136 (54) | 177 (63) | 124 (57) | 209 (63) |
| Negative | 52 (23) | 73 (25) | 20 (25) | 20 (22) | 73 (29) | 63 (22) | 62 (29) | 73 (22) |
| Don’t now | 41 (18) | 41 (14) | 10 (12) | 21 (23) | 41 (17) | 41 (15) | 31 (14) | 52 (15) |
| Income | ||||||||
| SC Farming | 105 (46) | 127 (44) | 20 (25) | 31 (34) | 117 (47) | 127 (45) | 85 (39) | 159 (48) |
| SC Business | 103 (45) | 134 (46) | 40 (50) | 40 (44) | 113 (45) | 124 (44) | 102 (47) | 145 (43) |
| Employed | 20 (9) | 30 (10) | 20 (25) | 20 (22) | 20 (8) | 30 (11) | 30 (14) | 30 (9) |
| Education | ||||||||
| None | 10 (4) | 32 (11) | 10 (13) | 10 (11) | 32 (13) | 43 (16) | 10 (5) | 43 (13) |
| Primary | 136 (60) | 147 (51) | 30 (37) | 41 (45) | 136 (54) | 147 (52) | 95 (44) | 179 (53) |
| Secondary | 52 (23) | 62 (21) | 20 (25) | 20 (22) | 52 (21) | 51 (18) | 62 (28) | 62 (19) |
| Tertiary | 30 (13) | 50 (17) | 20 (25) | 20 (22) | 30 (12) | 40 (14) | 50 (23) | 50 (15) |
| Treatment | ||||||||
| Chemo | 32 (14) | 32 (11) | 10 (11) | 10 (11) | 32 (13) | 32 (11) | 32 (15) | 32 (10) |
| Chemo+rad | 11 (5) | 11 (4) | 0 | 0 | 11 (4) | 11 (4) | 11 (5) | 11 (3) |
| Surgery | 20 (9) | 20 (7) | 20 (25) | 20 (22) | 20 (8) | 20 (7) | 10 (5) | 30 (9) |
| Bld tran+Pan k | 94 (41) | 94 (32) | 0 | 11 (12) | 94 (38) | 94 (34) | 63 (29) | 105 (31) |
| Pain killers | 31 (14) | 63 (21) | 20 (25) | 20 (22) | 63 (25) | 42 (15) | 41 (19) | 74 (22) |
| Haematemics | 40 (17) | 40 (14) | 30 (37) | 30 (33) | 30 (12) | 40 (14) | 40 (18) | 40 (12) |
| LEEP | 0 | 31 (10) | 0 | 0 | 0 | 42 (15) | 20 (9) | 42 (13) |
| Insurance | ||||||||
| Yes | 30 (13) | 30 (10) | 20 (25) | 20 (22) | 30 (12) | 30 (10) | 30 (14) | 30 (9) |
| No | 198 (87) | 261 (90) | 60 (75) | 71 (78) | 220 (88) | 251 (90) | 187 (86) | 304 (91) |
| Total | 228 (100) | 291 (100) | 80 (100) | 91 (100) | 250 (100) | 281 (100) | 217 (100) | 334 (100) |
